Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol

Nikiforow, S., Whangbo, J. S., Reshef, R., Tsai, D. E., Bunin, N., Abu-Arja, R., Mahadeo, K. M., Weng, W.-K., Van Besien, K., Loeb, D., Nasta, S. D., Nemecek, E. R., Zhao, W., Sun, Y., Galderisi, F., Wahlstrom, J., Mehta, A., Gamelin, L., Dinavahi, R., & Prockop, S. (2024). Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Advances, 8(12), 3001–3012. https://doi.org/10.1182/bloodadvances.2023011626
Authors:
Sarah Nikiforow
Jennifer Whangbo
Ran Reshef
Donald E. Tsai
Nancy Bunin
Rolla Abu‐Arja
Kris M. Mahadeo
Wen‐Kai Weng
Koen van Besien
David M. Loeb
Sunita D. Nasta
Eneida R. Nemecek
Weizhi Zhao
Yan Sun
Faith Galderisi
Justin T. Wahlstrom
Aditi Mehta
Laurence Gamelin
Rajani Dinavahi
Susan E. Prockop
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Subjects:
Hematopoietic Stem Cell Transplantation (MeSH)
Lymphoproliferative Disorders (MeSH)
Epstein-Barr Virus Infections (MeSH)
Transplantation, Homologous (MeSH)
Viral-Related Cancers in Immunocompromised Patients (OpenAlex Topic)
Lymphoid Neoplasms (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2023011626
PMID:
38625984
DOI:
10.1182/bloodadvances.2023011626
Journal:
Blood Advances
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: